X0708 D LIVE 0001676163 SS Innovations International, Inc. 405, 3RD FLOOR, ILABS INFO TECH CENTRE UDYOG VIHAR, PHASE III GURUGRAM, HARYANA K7 INDIA 122016 +91 73375 53469 FLORIDA None AVRA Medical Robotics, Inc. Corporation true Sudhir Prem Srivastava 405, 3rd Floor, iLabs Info Tech Centre Udyog Vihar, Phase III Gurugram, Haryana K7 INDIA 122016 Executive Officer Director Chairman and Chief Executive Officer Milan Rao 405, 3rd Floor, iLabs Info Tech Centre Udyog Vihar, Phase III Gurugram, Haryana K7 INDIA 122016 Executive Officer Global Chief Operating Officer and Chief Financial Officer Vishwajyoti P. Srivastava 405, 3rd Floor, iLabs Info Tech Centre Udyog Vihar, Phase III Gurugram, Haryana K7 INDIA 122016 Executive Officer Director Chief Executive Officer - Asia Pacific and Director Barry F. Cohen 405, 3rd Floor, iLabs Info Tech Centre Udyog Vihar, Phase III Gurugram, Haryana K7 INDIA 122016 Executive Officer Director Chief Operating Officer - Americas and Director Mylswamy F. Annadurai 405, 3rd Floor, iLabs Info Tech Centre Udyog Vihar, Phase III Gurugram, Haryana K7 INDIA 122016 Director Director S.P. Somashekhar 405, 3rd Floor, iLabs Info Tech Centre Udyog Vihar, Phase III Gurugram, Haryana K7 INDIA 122016 Director Director Frederic H. Moll 405, 3rd Floor, iLabs Info Tech Centre Udyog Vihar, Phase III Gurugram, Haryana K7 INDIA 122016 Director Director Tim Adams 405, 3rd Floor, iLabs Info Tech Centre Udyog Vihar, Phase III Gurugram, Haryana K7 INDIA 122016 Director Director Biotechnology $25,000,001 - $100,000,000 06b false 2026-03-06 false true false 75000 Roth Capital Partners, LLC 000015407 None None 888 San Clemente Suite 400 Newport Beach CA CALIFORNIA 92660 FL FLORIDA false 18621498 18621498 0 false 25 175000 0 In addition to the cash compensation the above mentioned Recipient will be issued five-year warrants to purchase 41,667 shares of our common stock at an exercise price of $3.45 per share. 0 false SS Innovations International, Inc. /s/ Sudhir Prem Srivastava Sudhir Prem Srivastava, M.D. Chairman and Chief Executive Officer 2026-03-19